There is provided a method of rapidly relieving pain in a mammalian, preferably human, subject. The method comprises orally administering to the subject an effective pain-relieving amount of a composition comprising celecoxib formulated in such a way as to provide, when tested in fasting humans in accordance with standard pharmacokinetic practice, a blood plasma concentration profile of celecoxib in which a concentration of about 250 ng/ml is attained not later than about 30 minutes after oral administration.

 
Web www.patentalert.com

< Wnt-7B-like polypeptides and nucleic acids encoding same

< Pyrazinone thrombin inhibitors

> Nucleic acids and polypeptides

> Multiple-light cold-cathode tube lighting device

~ 00075